Type 2 diabetes in adults: management (medicines update)Status:In developmentProgramme:NICE guidelineExpected publication date: 18 February 2026
Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes [ID6259]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 8 April 2026
Insulin efsitora alfa for treating type 2 diabetes ID6499Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 22 October 2026
Diabetic retinopathy - ruboxistaurin [ID382]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Insulin icodec for treating type 2 diabetes [ID6175]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Cardiometabolic disease prevention and treatment guidelinesStatus:In developmentProgramme:NICE HubExpected publication date: TBC
Insulin efsitora alfa for treating type 1 diabetes in people on multiple daily insulin injections [ID6498]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC